Compare Cytokinetics Inc (CYTK) vs Progressive Corp (PGR) Price & Performance

Cytokinetics IncTrade

Progressive CorpTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs Progressive Corp — how do they compare? Cytokinetics Inc trades at $77.39 (market cap $10.63B), while Progressive Corp trades at $211.9 (market cap $123.45B). The key difference: Progressive Corp is far larger — about 11.6× Cytokinetics Inc's market cap, and Progressive Corp pays a 6.55% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.

	CYTK	PGR
Market Cap	$10.63B	$123.45B
Sector	Technology	Financials
52-Week High	$87.26	$252.68
52-Week Low	$34.31	$190.40
Enterprise Value	$10.74B	$131.66B
Dividend Yield	—	6.55%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cytokinetics Inc

Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.

The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.

Progressive Corp

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.